PHARMACOGENETIC EFFECTS OF NALTREXONE IN INDIVIDUALS OF EAST ASIAN DESCENT: HUMAN LABORATORY FINDINGS FROM A RANDOMIZED TRIAL

BACKGROUND: Genetic variation in the endogenous opioid system has been identified as one potential source of individual variability in naltrexone treatment outcomes. The majority of naltrexone pharmacogenetic studies have focused on a particular single nucleotide polymorphism (SNP) of the mu-opioid...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Alcohol Clin Exp Res
Главные авторы: Ray, Lara A., Green, ReJoyce, Roche, Daniel J.O., Bujarski, Spencer, Hartwell, Emily E., Lim, Aaron C., Rohrbaugh, Taylor, Ghahremani, Dara, Hutchison, Kent, Miotto, Karen
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6086578/
https://ncbi.nlm.nih.gov/pubmed/29265379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13586
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы